SANUWAVE Health, Inc. Common Stock (SNWV) - Total Liabilities

Latest as of March 2026: $35.26 Million USD

Based on the latest financial reports, SANUWAVE Health, Inc. Common Stock (SNWV) has total liabilities worth $35.26 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore SANUWAVE Health, Inc. Common Stock equity growth rate to track the company's year-over-year net asset growth rate.

SANUWAVE Health, Inc. Common Stock - Total Liabilities Trend (2006–2025)

This chart illustrates how SANUWAVE Health, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. See SNWV FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

SANUWAVE Health, Inc. Common Stock Competitors by Total Liabilities

The table below lists competitors of SANUWAVE Health, Inc. Common Stock ranked by their total liabilities.

Company Country Total Liabilities
Seoul Auction Co. Ltd
KQ:063170
Korea ₩118.07 Billion
Dsr Wire
KO:069730
Korea ₩69.74 Billion
China Bicycle Co Holdings Ltd
SHE:200017
China CN¥93.60 Million
Yesil Gayrimenkul Yatirim Ortakligi AS
IS:YGYO
Turkey TL7.54 Billion
Orient Ceratech Limited
NSE:ORIENTCER
India Rs1.20 Billion
Chilwa Minerals Ltd
AU:CHW
Australia AU$1.60 Million
BP Plastics Holding Bhd
KLSE:5100
Malaysia RM48.28 Million
Sajo Oyang
KO:006090
Korea ₩198.54 Billion

Liability Composition Analysis (2006–2025)

This chart breaks down SANUWAVE Health, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SNWV company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.31 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 19.18 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.95 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SANUWAVE Health, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SANUWAVE Health, Inc. Common Stock (2006–2025)

The table below shows the annual total liabilities of SANUWAVE Health, Inc. Common Stock from 2006 to 2025.

Year Total Liabilities Change
2025-12-31 $35.72 Million -16.60%
2024-12-31 $42.84 Million -34.70%
2023-12-31 $65.59 Million +7.74%
2022-12-31 $60.88 Million +5.74%
2021-12-31 $57.58 Million +56.69%
2020-12-31 $36.75 Million +173.30%
2019-12-31 $13.45 Million -18.68%
2018-12-31 $16.53 Million +48.16%
2017-12-31 $11.16 Million +40.97%
2016-12-31 $7.92 Million +15.80%
2015-12-31 $6.84 Million +9.95%
2014-12-31 $6.22 Million -19.42%
2013-12-31 $7.72 Million -7.81%
2012-12-31 $8.37 Million +8.66%
2011-12-31 $7.70 Million -43.13%
2010-12-31 $13.55 Million +15.27%
2009-12-31 $11.75 Million +15322.39%
2008-12-31 $76.20K +47.75%
2007-12-31 $51.57K +25.93%
2006-12-31 $40.95K --

About SANUWAVE Health, Inc. Common Stock

NASDAQ:SNWV USA Medical Devices
Market Cap
$53.06 Million
Market Cap Rank
#21599 Global
#4772 in USA
Share Price
$6.17
Change (1 day)
-1.91%
52-Week Range
$5.92 - $16.47
All Time High
$16.47
About

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses no… Read more